Connect your AI

KEEL KEEL Issuance Through Atthe Market Equity Offering Program

Issuance Through Atthe Market Equity Offering Program at other companies

Apogee Therapeutics, Inc.APGE

$16.4M+50.7%

Viking TherapeuticsVKTX

$11.63M—

GTY

Getty RealtyGTY

$19.92M+80.9%

Taysha Gene Therapies, Inc.TSHA

$12.11M—

Revolution Medicines, Inc.RVMD

$226.73M—

Red Cat Holdings, Inc.RCAT

$0—

Other financials

Income statement

Revenue$37.0M-22.4%

Gross profit-$26.3M-9,631%

Operating income-$98.4M-182%

Net income-$145.4M-162%

EPS (diluted)-$0.24-118%

Balance sheet

Cash & equivalents$357.3M+827%

Total debt$591.0M—

Total equity$419.1M-36.6%

Total assets$1.1B—

Cash flow

Operating cash flow-$64.7M-243%

CapEx$10.3M-76.2%

Free cash flow-$75.0M-20.6%

Valuation

Market cap$3.99B—

Profitability

Gross margin-7.9%-2.8pp

Operating margin-37.8%+2.0pp

Net margin-52%+24.6pp

FCF margin-259.9%+201pp

Returns & leverage

Return on equity-6.1%-2.5pp

Debt / equity1.4×—

Current ratio9.6×—

Where this comes from

Reported directly by KEEL in its filing.

Tagged under the XBRL concept bitf:IssuanceThroughAttheMarketEquityOfferingProgram.

The official record: KEEL’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about KEEL's issuance through atthe market equity offering program.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is KEEL's issuance through atthe market equity offering program?: KEEL (KEEL) reported issuance through atthe market equity offering program of 29.6M in Q4 2025.
What does issuance through atthe market equity offering program mean?: This represents the cash proceeds or share issuance resulting from an 'at-the-market' (ATM) equity offering program. It reflects the company's ability to raise capital by selling shares directly into the secondary market at prevailing market prices. This is a common liquidity management tool for capital-intensive industries like cryptocurrency mining.